Biogen Inc.: New Data at ECTRIMS 2022 Highlight Biogen's Com

Final safety and efficacy results from the Phase 3 EVOLVE-MS-1 trial demonstrate decreases in disease activity and favorable tolerability for VUMERITY (diroximel fumarate) consistent with previous

Related Keywords

Germany , Nile , Tasmania , Australia , Ruhr , Nordrhein Westfalen , Netherlands , Bochum , Cambridge , Cambridgeshire , United Kingdom , Canada , Switzerland , German , Dutch , Maha Radhakrishnan , Charles Weissmann , Walter Gilbert , Heinz Schaller , Allison Parks , Mike Hencke , Diroximel Fumarate , Kenneth Murray , Linkedin , Twitter , Unilabs Customer Satisfaction Survey , Child Development , Observational Program , University Bochum , Nasdaq , Exchange Commission , Youtube , Outcomes On Child Development , European Union , Facebook , Research In Multiple Sclerosis , European Committee For Treatment , European Committee , Multiple Sclerosis , Chief Medical Officer , Efficacy Results , Highlight Patient Reported Outcomes , Analysis Shows Impact , Ralf Gold , Ruhr University Bochum , Radiologically Isolated Syndrome Reported , Radiologically Isolated Syndrome , German Multiple Sclerosis , Pregnancy Registry , Data Presentations Featured , Report Better Outcomes , Treatment Satisfaction , Unique Benefits Than Similar Patients Treated , Pregnancy Outcomes After Long Term Exposure , Natalizumab During Pregnancy , German Multicentre , Open Label Study Over , Interim Analysis , Term Effectiveness , Global Interim Results , Magnetic Resonance Imaging Endpoints , Randomized Controlled Study , Week Dosing , Week Treatment , Exposure During Pregnancy , Natalizumab Patients , Unilabs Global Cohort Data Descriptive Analysis , Unilabs Customer Satisfaction Survey Results , Adjusted Indirect Comparisons , Relapsing Multiple Sclerosis , Relapsing Remitting Multiple Sclerosis , Final Safety , Beta Exposure During Pregnancy , Birth Outcome , Post Authorisation Safety Study , Double Blinded Assessment , Dimethyl Fumarate , First Clinical Demyelinating Event , West Nile , Important Safety Informationand , Prescribing Information , Medication Guidefor , Sir Kenneth Murray , Nobel Prize , Healthy Lives , Private Securities Litigation Reform Act , Biogen , Data , Actrims , 022 , Highlight , Commitment , Dvancing , Individualized , Disease , Management , People , Diving ,